Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124844462 | 12484446 | 2 | F | 20160529 | 20160902 | 20160621 | 20160916 | EXP | FR-PFIZER INC-2016292647 | PFIZER | 13.00 | YR | F | Y | 43.00000 | KG | 20160916 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124844462 | 12484446 | 1 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, UNK | Y | 71484 | 2 | MG | |||||||
| 124844462 | 12484446 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 4300 MG, UNK | Y | 0 | 4300 | MG | |||||||
| 124844462 | 12484446 | 3 | SS | DOXORUBICINE TEVA | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 29 MG, UNK | Y | 0 | 29 | MG | |||||||
| 124844462 | 12484446 | 4 | SS | ETOPOSIDE TEVA | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 220 MG, UNK | Y | 0 | 220 | MG | |||||||
| 124844462 | 12484446 | 5 | C | ZOPHREN /00955301/ | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 998 MG, UNK | 0 | 998 | MG | ||||||||
| 124844462 | 12484446 | 6 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Intravenous (not otherwise specified) | 43 MG, UNK | 0 | 43 | MG | ||||||||
| 124844462 | 12484446 | 7 | C | UROMITEXAN | MESNA | 1 | Intravenous (not otherwise specified) | 5184 MG, UNK | 0 | 5184 | MG | ||||||||
| 124844462 | 12484446 | 8 | C | VOGALENE | METOPIMAZINE | 1 | 14.19 MG THRICE | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124844462 | 12484446 | 1 | Ewing's sarcoma |
| 124844462 | 12484446 | 2 | Ewing's sarcoma |
| 124844462 | 12484446 | 3 | Ewing's sarcoma |
| 124844462 | 12484446 | 4 | Ewing's sarcoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124844462 | 12484446 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124844462 | 12484446 | Depressed level of consciousness | |
| 124844462 | 12484446 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124844462 | 12484446 | 1 | 20160527 | 20160527 | 0 | |
| 124844462 | 12484446 | 2 | 20160527 | 20160529 | 0 | |
| 124844462 | 12484446 | 3 | 20160527 | 20160529 | 0 | |
| 124844462 | 12484446 | 4 | 20160527 | 20160529 | 0 |